News from takeda pharmaceutical company limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 27, 2015, 06:00 ET DNDi and Takeda Collaborate for the Lead Optimization for Aminopyrazole Series for Visceral Leishmaniasis

Drugs for Neglected Diseases initiative (Headquarters: Geneva, Switzerland; Executive Director: Bernard Pécoul, Doctor; "DNDi") and Takeda...


Jun 05, 2015, 05:15 ET Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Takeda Pharmaceutical Company Limited, ("Takeda") today announced additional post-hoc analyses from the global EXAMINE (EXamination of CArdiovascular ...


May 15, 2015, 02:26 ET Takeda Reports Top Line Results in Line With Guidance, With Underlying Growth of +2.8% EPS Affected by One-time Charges in FY2014 Back to Profitable Growth from FY2015 Onward

Operational guidance met Underlying revenue +2.8% year-over-year, in line with guidance (reported revenue growing +5.1% to 1,777.8 billion yen)...


Apr 13, 2015, 08:40 ET Takeda Announces Appointment of New President of U.S. Business Unit

Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA") announced today ...


Mar 09, 2015, 08:20 ET Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular...


Mar 09, 2015, 01:15 ET Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology

Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's...


Oct 27, 2014, 11:00 ET Trate los síntomas del reflujo gracias a la Food4GERD App

La enfermedad del reflujo gastroesofágico (GERD), a menudo conocida como ardor de estómago, es un problema importante para muchas personas en todo el ...


Oct 20, 2014, 08:00 ET Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults

Takeda Pharmaceutical Company Limited ("Takeda"), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc....


Aug 28, 2014, 12:09 ET Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from a...


Jul 10, 2014, 09:00 ET Takeda and Zinfandel Pharmaceuticals to Present Data at Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches to Alzheimer's Disease Research and Development

Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), will present data during multiple...


Jun 17, 2014, 09:00 ET Results of a New Study of Brintellix® (vortioxetine) vs. Escitalopram on Sexual Functioning in Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction

Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual...


Jun 16, 2014, 10:00 ET ENTYVIO™ (vedolizumab) Now Available in the United States for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis and Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the United...


Jun 16, 2014, 06:30 ET New CONNECT Study Presents data on Measures of Cognitive Performance in Adult Patients Treated with Brintellix® (vortioxetine) for Major Depressive Disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated the...


May 20, 2014, 06:14 ET FDA Approves Takeda's Entyvio™ (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...


Mar 27, 2014, 08:00 ET Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN...


Dec 24, 2013, 10:57 ET Takeda Announces Extension of FDA PDUFA Action Date for Vedolizumab for Ulcerative Colitis

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...


Dec 09, 2013, 08:09 ET FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint...


Sep 20, 2013, 09:00 ET Takeda Cares Day Raises $63,700

Takeda, a top 15 global pharmaceutical company, will raise money for local organizations today when employees participate in their third annual...


Sep 17, 2013, 02:38 ET Takeda's Deerfield Campus Ranked Among 2013 Working Mother 100 Best Companies

Takeda Pharmaceuticals today announced Working Mother has listed Takeda among the top 100 companies for working mothers. Takeda's Deerfield campus...


Sep 12, 2013, 01:45 ET Takeda and Arbor Announce a Licensing Agreement for EDARBI and EDARBYCLOR

Takeda Pharmaceutical Company Limited (Takeda) and Arbor Pharmaceuticals Ireland Ltd., a wholly-owned subsidiary of Arbor Pharmaceuticals, LLC...


Sep 11, 2013, 02:06 ET EXAMINE-Studie zur kardiovaskulären Sicherheit von Alogliptin erreicht primären Endpunkt: keine Erhöhung des kardiovaskulären Risikos bei Risikopatienten mit Typ-2 Diabetes

Takeda Pharmaceutical Company Limited (Takeda) gab heute die Ergebnisse der Studie zur kardiovaskulären Sicherheit EXAMINE bekannt. EXAMINE steht für ...


Sep 04, 2013, 01:15 ET Takeda's New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...


Aug 26, 2013, 11:40 ET Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm

Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), today announced the initiation of...